心脏骤停后目标温度管理中的复极与室性心律失常
本研究为TTM试验(33°C vs 36°C)的ECG亚组分析,纳入680例(94%)院外心脏骤停患者,连续监测ECG。结果显示33°C较36°C更显著延长QT、QTc和QTp间期,但复温后恢复;TpTe间期在TTM期间维持在92-100 ms。QTc与室性心律失常相关,但校正心脏骤停特征后不再显著;QTp无关联;
要点
- 33°C较36°C更显著延长QT、QTc和QTp间期,但QTc与室性心律失常的关联在校正心脏骤停特征后消失。
- QTp间期与室性心律失常风险无关;TpTe间期受核心温度影响不显著。
适用人群与场景
- 院外心脏骤停(OHCA)后接受目标温度管理(TTM)的患者,来自TTM试验的ECG亚组(680例,94%)。
诊断标准与关键阈值
- 采用Bazett和Fridericia公式进行心率校正;TpTe间期阈值≥90 ms与室性心律失常风险升高相关。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:TTM试验(33°C vs 36°C)的ECG亚组分析;样本量680例(94%),多中心(原文未提具体中心数);人群为OHCA后TTM患者。
- 主要终点:室性心律失常(VT/VF)在心脏骤停后前3天内记录。
- QTc与室性心律失常相关,但校正心脏骤停特征后不再显著;QTp无关联。
- 33°C较36°C更显著延长QT、QTc和QTp间期,复温后恢复至相似或更低水平;TpTe间期在TTM期间维持92-100 ms。
证据类型、等级与局限
- 证据类型:随机对照试验(TTM试验)的ECG亚组分析;证据等级原文未提及;局限包括亚组分析、样本量680例、单中心?原文未提中心数,但为TTM试验亚组。
对床旁实践的改变
- 在心脏骤停后TTM患者中,心率校正的TpTe间期≥90 ms可能有助于识别室性心律失常高风险患者,但需前瞻性验证。
- QTc延长在TTM期间常见,但校正心脏骤停特征后与室性心律失常无关,不应单独作为心律失常风险指标。
指南或共识出处
- TTM试验(ClinicalTrials.gov Identifier: NCT01020916)
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Targeted temperature management (TTM) following out-of-hospital cardiac arrest (OHCA) prolongs the QT-interval but our knowledge of different temperatures and risk of arrhythmia is incomplete.
OBJECTIVE: To assess whether the QTc, QT-peak (QTp) and T-peak to T-end interval (TpTe) may be useful markers of ventricular arrhythmia in contemporary post cardiac arrest treatment.
METHODS: An ECG-substudy of the TTM-trial (TTM at 33 °C vs. 36 °C) with serial ECGs from 680 (94%) patients. Bazett's (B) and Fridericia's (F) formula were used for heart rate correction of the QT, QTp and TpTe. Ventricular arrhythmia (VT/VF) were registered during the first three days of post cardiac arrest care.
RESULTS: The QT, QTc and QTp intervals were prolonged more at 33 °C compared to 36 °C and restored to similar and lower levels after rewarming. The TpTe-interval remained between 92-100 ms throughout TTM in both groups. The QTc intervals were associated with ventricular arrhythmia, but not after adjustment for cardiac arrest characteristics. The QTp-interval was not associated with risk of ventricular arrhythmia. Heart rate corrected TpTe-intervals were associated with higher risk of arrhythmia (Odds ratio (OR): TpTe(B): 1.12 (1.02-1.23, p = 0.01 TpTe(F): 1.12 (1.02-1.23, p = 0.02) per 20 ms). Further a prolonged TpTe-interval ≥ 90 ms was consistently associated with higher risk (ORadjusted: TpTe(B): 2.05 (1.25-3.37), p < 0.01, TpTe(F): 2.14 (1.32-3.49), p < 0.01).
CONCLUSIONS: TTM prolongs the QT-interval by prolongation of the QTp-interval without association to increased risk. The TpTe-interval is not significantly affected by core temperature, but heart rate corrected TpTe intervals are robustly associated with risk of ventricular arrhythmia.
TRIAL REGISTRATION: The TTM-trial is registered and accessible at ClinicalTrials.gov (Identifier: NCT01020916).
参考来源
- Thomsen JH, Hassager C, Erlinge D, et al. Repolarization and ventricular arrhythmia during targeted temperature management post cardiac arrest. Resuscitation. 2021. PMID: 34271131. doi:10.1016/j.resuscitation.2021.07.004
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。